Inventor · disambiguated record
Rodger F. Henry
Also filed as: HENRY RODGER · HENRY RODGER F · ROZEMA MICHAEL J · WANG WEILI W
34 granted patents·25 pending applications·242 citations·filing 1994–2023
97Inventor score
Top patents by PatentIndex Score
59 records- 0196US7728143B2Salt and crystalline forms thereof of a drugABBOTT LAB·Filed 2005·Granted Jun 1, 2010·13 cites·7 claims
- 0295US8648093B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2012·Granted Feb 11, 2014·7 cites·32 claims
- 0394US8273892B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2010·Granted Sep 25, 2012·9 cites·1 claims
- 0494US8252813B2Salt and crystalline forms thereof of a drugZHANG GEOFF G Z·Filed 2010·Granted Aug 28, 2012·10 cites·38 claims
- 0594US7820812B2Methods of manufacturing crystalline forms of rapamycin analogsABBOTT LAB·Filed 2007·Granted Oct 26, 2010·17 cites·21 claims
- 0693US8314119B2Azaadamantane derivatives and methods of useSCHRIMPF MICHAEL R·Filed 2007·Granted Nov 20, 2012·22 cites·20 claims
- 0792US8969569B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2014·Granted Mar 3, 2015·5 cites·35 claims
- 0888US7354937B2(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptaneABBOTT LAB·Filed 2005·Granted Apr 8, 2008·6 cites·4 claims
- 0986US9446059B2Carbidopa and L-dopa prodrugs and methods of useABBVIE INC·Filed 2015·Granted Sep 20, 2016·5 cites·24 claims
- 1086US8034926B2Methods of manufacturing crystalline forms of rapamycin analogsABBOTT LAB·Filed 2010·Granted Oct 11, 2011·4 cites·25 claims
- 1186US7812032B2Crystalline forms of rapamycin analogsABBOTT LAB·Filed 2007·Granted Oct 12, 2010·8 cites·18 claims
- 1285US9539250B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2015·Granted Jan 10, 2017·3 cites·53 claims
- 1385US8987453B2Azaadamantane derivatives and methods of useABBVIE INC·Filed 2012·Granted Mar 24, 2015·6 cites·6 claims
- 1484US7943782B2Crystalline chemotherapeuticABBOTT LAB·Filed 2008·Granted May 17, 2011·8 cites·3 claims
- 1584US7538226B2(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptaneABBOTT LAB·Filed 2007·Granted May 26, 2009·4 cites·2 claims
- 1684US5945405ACrystal form O of clarithromycinABBOTT LAB·Filed 1997·Granted Aug 31, 1999·62 cites·25 claims
- 1782US9873681B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2016·Granted Jan 23, 2018·1 cites·30 claims
- 1881US8030326B2Crystalline forms of rapamycin analogsABBOTT LAB·Filed 2010·Granted Oct 4, 2011·5 cites·15 claims
- 1980US10329276B2Salt and crystalline forms thereof of a drugABBVIE INC·Filed 2017·Granted Jun 25, 2019·1 cites·23 claims
- 2080US2023106081A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2022·Application pending·0 cites
- 2178US8178548B2Anti-infective agents and uses thereofDONNER PAMELA L·Filed 2008·Granted May 15, 2012·4 cites·57 claims
- 2275US6864369B2Crystalline pharmaceuticalABBOTT LAB·Filed 2003·Granted Mar 8, 2005·5 cites·14 claims
- 2375US2022153765A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2021·Application pending·0 cites
- 2471US8362013B2Salt of ABT-263 and solid-state forms thereofABBVIE INC·Filed 2010·Granted Jan 29, 2013·2 cites·10 claims
- 2570US7745448B2Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolateABBOTT LAB·Filed 2006·Granted Jun 29, 2010·2 cites·2 claims
- 2670US2014303369A1Crystalline PharmaceuticalABBVIE INC·Filed 2014·Application pending·0 cites
- 2767US6627743B16-O-methylerythromycin A crystal form IIIABBOTT LAB·Filed 1999·Granted Sep 30, 2003·21 cites·6 claims
- 2865US2010048534A1Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranateABBOTT LAB·Filed 2009·Application pending·0 cites
- 2965US2005124810A1Crystalline pharmaceuticalFiled 2004·Application pending·0 cites
- 3065US2010048533A1Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimibABBOTT LAB·Filed 2009·Application pending·0 cites
- 3162US7589194B2Crystalline k-252b, sodium salt, methanolate pentahydrateABBOTT LAB·Filed 2008·Granted Sep 15, 2009·0 cites·1 claims
- 3262US7585972B2Crystalline K-252α bis(tetrahydrofuranate)ABBOTT LAB·Filed 2008·Granted Sep 8, 2009·0 cites·1 claims
- 3362US2024024338A1Carbidopa and l-dopa prodrugs and methods of useABBVIE INC·Filed 2023·Application pending·0 cites
- 3461US8058433B2Crystalline pharmaceuticalDICKMAN DANIEL A·Filed 2006·Granted Nov 15, 2011·0 cites·39 claims
- 3560US8796451B2Crystalline pharmaceuticalDICKMAN DANIEL A·Filed 2011·Granted Aug 5, 2014·0 cites·17 claims
- 3660US2009203664A1(1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- diazabicyclo[3.2.0]heptaneABBOTT LAB·Filed 2009·Application pending·0 cites
- 3758US2016362431A1Carbidopa And L-Dopa Prodrugs And Methods Of UseABBVIE INC·Filed 2016·Application pending·0 cites
- 3856US2007135401A1Lestaurtinib Crystalline Form 1, crystalline lestaurimib anhydrate and amorphous lestaurimibDZIKI WALTER·Filed 2006·Application pending·0 cites
- 3956US2007135628A1Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranateDZIKI WALTER·Filed 2006·Application pending·0 cites
- 4055US5504207AProcess and intermediate for the preparation of terazosin hydrochloride dihydrateABBOTT LAB·Filed 1994·Granted Apr 2, 1996·12 cites·4 claims
- 4155US2023183236A1Crystalline forms of an apoptosis-inducing agentABBVIE INC·Filed 2021·Application pending·0 cites
- 4252US2008177063A1CRYSTALLINE K-252b, SODIUM SALT, HYDRATEABBOTT LAB·Filed 2008·Application pending·0 cites
- 4352US2008177062A1CRYSTALLINE K-252a BIS(N,N' DIMETHYLFORMAMIDATE)ABBOTT LAB·Filed 2008·Application pending·0 cites
- 4452US2008171866A1CRYSTALLINE K-252a BIS(METHANOLATE)ABBOTT LAB·Filed 2008·Application pending·0 cites
- 4552US2008132710A1Atrasentan hydrochloride crystalline form 2ABBOTT LAB·Filed 2007·Application pending·0 cites
- 4650US2012028908A1Methods of Manufacturing Crystalline Forms of Rapamycin AnalogsVISWANATH SHEKHAR·Filed 2011·Application pending·0 cites
- 4750US2005209211A1Trihemihydrate, anhydrate and novel hydrate forms of CefdinirLAW DEVALINA·Filed 2005·Application pending·0 cites
- 4848US8986740B2Anti-infective agents and uses thereofDONNER PAMELA L·Filed 2012·Granted Mar 24, 2015·0 cites·40 claims
- 4948US7745622B2Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonateABBOTT LAB·Filed 2006·Granted Jun 29, 2010·0 cites·2 claims
- 5048US7449584B2N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1ABBOTT LAB·Filed 2006·Granted Nov 11, 2008·0 cites·1 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rodger F. Henry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →